Welcome to BioMarket Group!

Line of Treatment

In this section you will find Therapeutics Line of Treatment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

2 Item(s)

per page

Set Ascending Direction
  1. Protein Kinase Inhibitors in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 462 companies plus partners who are today developing 831 PKI drugs in 2912 developmental projects in cancer across 296 different targets. In addition, there are 5 suspended drugs and another 459 drugs where development has been ceased. Learn More

  2. Analytical Tool - Angiogenesis in Oncology

    $4,650.00
    Published by BioSeeker Group on Mar 25th, 2014
    The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

2 Item(s)

per page

Set Ascending Direction

Line of Treatment

In this section you will find Therapeutics Line of Treatment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

2 Item(s)

per page

Set Ascending Direction
  1. Protein Kinase Inhibitors in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 462 companies plus partners who are today developing 831 PKI drugs in 2912 developmental projects in cancer across 296 different targets. In addition, there are 5 suspended drugs and another 459 drugs where development has been ceased. Learn More

  2. Analytical Tool - Angiogenesis in Oncology

    $4,650.00
    Published by BioSeeker Group on Mar 25th, 2014
    The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

2 Item(s)

per page

Set Ascending Direction